Department of Gastroenterology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Am J Gastroenterol. 2010 Nov;105(11):2357-67. doi: 10.1038/ajg.2010.253. Epub 2010 Jun 29.
Gastroparesis patients may have associated psychological distress. This study aimed to measure depression and anxiety in gastroparesis in relation to disease severity, etiology, and gastric retention.
Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI) scores for state (Y1) and trait (Y2) anxiety were obtained from 299 gastroparesis patients from 6 centers of the National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium. Severity was investigator graded as grades 1, 2, or 3 and patient reported by Gastroparesis Cardinal Symptom Index (GCSI) scores. Antiemetic/prokinetic medication use, anxiolytic and antidepressant medication use, supplemental feedings, and hospitalizations were recorded. BDI, Y1, and Y2 scores were compared in diabetic vs. idiopathic etiologies and mild (≤20%) vs. moderate (>20-35%) vs. severe (>35-50%) vs. very severe (>50%) gastric retention at 4 h.
BDI, Y1, and Y2 scores were greater with increasing degrees of investigator-rated gastroparesis severity (P<0.05). BDI, Y1, and Y2 scores were higher for GCSI >3.1 vs. ≤3.1 (P<0.05). Antiemetic and prokinetic use and ≥6 hospitalizations/year were more common with BDI ≥20 vs. <20 (P<0.05). Anxiolytic use was more common with Y1≥46; antidepressant use and ≥6 hospitalizations/year were more common with Y2≥44 (P<0.05). BDI, Y1, and Y2 scores were not different in diabetic and idiopathic gastroparesis and did not relate to degree of gastric retention. On logistic regression, GCSI >3.1 was associated with BDI ≥20 and Y1≥46; antiemetic/prokinetic use was associated with BDI≥20; anxiolytic use was associated with Y1≥46; and antidepressant use was associated with Y2≥44.
Higher depression and anxiety scores are associated with gastroparesis severity on investigator- and patient-reported assessments. Psychological dysfunction does not vary by etiology or degree of gastric retention. Psychological features should be considered in managing gastroparesis.
胃轻瘫患者可能存在相关的心理困扰。本研究旨在测量胃轻瘫患者的抑郁和焦虑程度,分析其与疾病严重程度、病因和胃潴留的关系。
从美国国立糖尿病、消化和肾脏疾病研究所胃轻瘫临床研究联盟的 6 个中心的 299 名胃轻瘫患者中获得贝克抑郁量表(BDI)和状态特质焦虑量表(STAI)的状态(Y1)和特质(Y2)焦虑评分。严重程度由研究者分级为 1 级、2 级或 3 级,患者报告胃轻瘫 cardinal 症状指数(GCSI)评分。记录止吐药/促动力药的使用、抗焦虑药和抗抑郁药的使用、补充喂养和住院情况。比较糖尿病与特发性病因、4 小时胃潴留率分别为≤20%、20%35%、35%50%和>50%时的 BDI、Y1 和 Y2 评分。
随着研究者评估的胃轻瘫严重程度的增加,BDI、Y1 和 Y2 评分也随之增加(P<0.05)。GCSI>3.1 与≤3.1 相比,BDI、Y1 和 Y2 评分更高(P<0.05)。BDI≥20 与<20 相比,止吐药和促动力药的使用以及每年≥6 次住院更为常见(P<0.05)。Y1≥46 时使用抗焦虑药更为常见;Y2≥44 时使用抗抑郁药和每年≥6 次住院更为常见(P<0.05)。糖尿病和特发性胃轻瘫患者的 BDI、Y1 和 Y2 评分无差异,且与胃潴留程度无关。在逻辑回归中,GCSI>3.1 与 BDI≥20 和 Y1≥46 相关;止吐药/促动力药的使用与 BDI≥20 相关;使用抗焦虑药与 Y1≥46 相关;使用抗抑郁药与 Y2≥44 相关。
研究者和患者评估的胃轻瘫严重程度与更高的抑郁和焦虑评分相关。心理功能障碍与病因或胃潴留程度无关。在治疗胃轻瘫时应考虑心理特征。